Jiangsu Hengrui Medicine
600276.SS
#494
Rank
A$64.67 B
Marketcap
$10.14
Share price
-0.62%
Change (1 day)
10.44%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Net assets

Net assets on the balance sheet as of September 2024 : A$10.11 Billion

According to Jiangsu Hengrui Medicine 's latest financial reports the company has A$10.11 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Jiangsu Hengrui Medicine - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2022-12-31$A$8.18 B6.29%
2021-12-31$A$7.70 B25.43%
2020-12-31$A$6.13 B20.4%
2019-12-31$A$5.09 B23.97%
2018-12-31$A$4.11 B31.02%
2017-12-31$A$3.13 B22.04%
2016-12-31$A$2.57 B17.25%
2015-12-31$A$2.19 B36.34%
2014-12-31$A$1.60 B30.5%
2013-12-31$A$1.23 B46.79%
2012-12-31$A$0.83 B23.63%
2011-12-31$A$0.67 B31.33%
2010-12-31$A$0.51 B19.11%
2009-12-31$A$0.43 B3.13%
2008-12-31$A$0.42 B62.25%
2007-12-31$A$0.25 B26.03%
2006-12-31$A$0.20 B9.73%
2005-12-31$A$0.18 B20.31%
2004-12-31$A$0.15 B6.13%
2003-12-31$A$0.14 B-15.36%
2002-12-31$A$0.17 B-3.21%
2001-12-31$A$0.17 B